-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Rice Hall James & Associates LLC Purchases New Shares in Doximity, Inc. (NASDAQ:DOCS)
Rice Hall James & Associates LLC Purchases New Shares in Doximity, Inc. (NASDAQ:DOCS)
Rice Hall James & Associates LLC purchased a new stake in Doximity, Inc. (NASDAQ:DOCS – Get Rating) during the third quarter, Holdings Channel reports. The institutional investor purchased 204,911 shares of the company's stock, valued at approximately $6,192,000.
A number of other institutional investors have also recently added to or reduced their stakes in DOCS. Bank of New York Mellon Corp grew its stake in Doximity by 60.6% in the 1st quarter. Bank of New York Mellon Corp now owns 172,855 shares of the company's stock valued at $9,004,000 after acquiring an additional 65,196 shares during the period. US Bancorp DE grew its stake in Doximity by 325.4% in the 1st quarter. US Bancorp DE now owns 2,646 shares of the company's stock valued at $138,000 after acquiring an additional 2,024 shares during the period. Cambridge Investment Research Advisors Inc. grew its stake in Doximity by 417.4% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 21,099 shares of the company's stock valued at $1,099,000 after acquiring an additional 17,021 shares during the period. Natixis Advisors L.P. acquired a new stake in Doximity in the 1st quarter valued at $983,000. Finally, BlackRock Inc. grew its stake in Doximity by 53.6% in the 1st quarter. BlackRock Inc. now owns 2,052,183 shares of the company's stock valued at $106,898,000 after acquiring an additional 716,547 shares during the period. Institutional investors and hedge funds own 52.48% of the company's stock.
Get Doximity alerts:Analysts Set New Price Targets
Several equities research analysts have issued reports on DOCS shares. BTIG Research started coverage on shares of Doximity in a research note on Thursday, October 13th. They set a "neutral" rating on the stock. Morgan Stanley cut shares of Doximity from an "equal weight" rating to an "underweight" rating and lowered their target price for the stock from $32.00 to $29.00 in a research note on Friday, January 6th. Evercore ISI lifted their target price on shares of Doximity from $28.00 to $32.00 in a research note on Friday, November 11th. Wells Fargo & Company lifted their target price on shares of Doximity from $38.00 to $44.00 and gave the stock an "overweight" rating in a research note on Friday, November 11th. Finally, Piper Sandler lowered their target price on shares of Doximity from $39.00 to $35.00 in a research note on Friday, November 11th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $41.40.
Doximity Trading Down 0.4 %
Shares of DOCS opened at $32.70 on Friday. The firm has a market cap of $6.29 billion, a P/E ratio of 50.31, a price-to-earnings-growth ratio of 16.89 and a beta of 0.86. Doximity, Inc. has a 12-month low of $22.91 and a 12-month high of $64.95. The company's 50-day moving average price is $32.76 and its 200 day moving average price is $33.60.Doximity (NASDAQ:DOCS – Get Rating) last issued its quarterly earnings data on Thursday, November 10th. The company reported $0.12 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.12. The firm had revenue of $102.19 million for the quarter, compared to analyst estimates of $99.86 million. Doximity had a net margin of 36.70% and a return on equity of 16.41%. Equities research analysts forecast that Doximity, Inc. will post 0.52 earnings per share for the current year.
Doximity Profile
(Get Rating)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Further Reading
- Get a free copy of the StockNews.com research report on Doximity (DOCS)
- MarketBeat: Week in Review 01/09-01/13
- JPMorgan Chase Falls As Banks Brace For Recession
- Why is the Bed Bath & Beyond Stock Price up 261%?
- Roku Stock Price is Trending, Here's Why
- Carvana Stock Rally, Here's What You Need to Know
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Get Rating).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
据控股频道报道,莱斯·霍尔·詹姆斯合伙人有限责任公司在第三季度收购了Doximity,Inc.(纳斯达克代码:DOCS-GET Rating)的新股份。该机构投资者购买了204,911股该公司股票,价值约为6,192,000美元。
其他一些机构投资者最近也增持或减持了DOCS的股份。纽约梅隆银行(Bank Of New York Mellon Corp)第一季度增持Doximity股份60.6%。纽约梅隆银行(Bank Of New York Mellon Corp)目前持有172,855股该公司股票,价值9,004,000美元,在此期间又购买了65,196股。US Bancorp DE在第一季度增持了325.4%的Doximity股份。US Bancorp DE现在拥有2646股该公司股票,价值13.8万美元,在此期间又购买了2024股。剑桥投资研究顾问公司(Cambridge Investment Research Advisors Inc.)在第一季度增持了417.4%的Doximity股份。剑桥投资研究顾问公司目前持有21,099股该公司股票,价值1,099,000美元,该公司在此期间增持了17,021股。Natixis Advisors L.P.在第一季度收购了Doximity的新股份,价值98.3万美元。最后,贝莱德股份有限公司在第一季度增持了53.6%的Doximity股份。贝莱德股份有限公司在此期间增持了716,547股,目前持有该公司2,052,183股股票,价值106,898,000美元。机构投资者和对冲基金持有该公司52.48%的股票。
到达多氧性警报:分析师设定新的价格目标
几位股票研究分析师已经发布了关于DOCS股票的报告。BTIG Research在10月13日星期四的一份研究报告中开始报道Doximity的股票。他们对该股设定了“中性”评级。1月6日,周五,摩根士丹利在一份研究报告中将Doximity的股票评级从持平下调至减持,并将其目标价从32.00美元下调至29.00美元。11月11日星期五,Evercore ISI在一份研究报告中将Doximity的目标价从28.00美元上调至32.00美元。富国银行将Doximity股票的目标价从38.00美元上调至44.00美元,并在11月11日星期五的一份研究报告中给予该股“增持”评级。最后,派珀·桑德勒在11月11日星期五的一份研究报告中将Doximity的目标股价从39.00美元下调至35.00美元。两名研究分析师对该股的评级为卖出,三名分析师给出了持有评级,八名分析师给出了该公司股票的买入评级。根据MarketBeat的数据,该公司的共识评级为持有,共识目标价为41.40美元。
Doximity交易下跌0.4%
DOCS的股票上周五开盘报32.70美元。该公司市值为62.9亿美元,市盈率为50.31倍,市盈率为16.89倍,贝塔系数为0.86。Doximity,Inc.的12个月低点为22.91美元,12个月高位为64.95美元。该公司的50日移动均线价格为32.76美元,200日移动均线价格为33.60美元。纳斯达克(Doximity:DOCS-GET Rating)最近一次发布季度收益数据是在11月10日星期四。该公司公布本季度每股收益(EPS)为0.12美元,符合市场普遍预期的0.12美元。该公司本季度营收为1.0219亿美元,而分析师预期为9986万美元。Doximity的净利润率为36.70%,股本回报率为16.41%。股票研究分析师预测,Doximity,Inc.本年度每股收益将为0.52美元。
多氧性分布
(获取评级)
Doximity,Inc.为美国的医疗专业人员运营着一个基于云的数字平台。该公司的平台为其成员提供了为医疗专业人员打造的工具,使他们能够与同事合作,协调患者护理,进行虚拟患者探视,了解最新的医学新闻和研究,并管理自己的职业生涯。
进一步阅读
- 免费获取StockNews.com关于Doximity的研究报告(DOCS)
- MarketBeat:回顾中的一周01/09-01/13
- 摩根大通破产,银行为衰退做好准备
- 为什么Bed Bath&Beyond的股价上涨了261%?
- Roku股价走势,原因如下
- Carvana Stock Rally,这是你需要知道的
想看看其他对冲基金持有哪些DOCS吗?访问HoldingsChannel.com获取Doximity,Inc.(纳斯达克:DOCS-GET Rating)的最新13F备案和内幕交易信息。
接受《多克莫斯日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Doximity和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧